Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease.

Georgiadou P, Iliodromitis EK, Varounis C, Mavroidis M, Kolokathis F, Andreadou I, Psarras S, Capetanaki Y, Boudoulas H, Kremastinos DT.

Expert Opin Ther Targets. 2008 Aug;12(8):917-20. doi: 10.1517/14728222.12.8.917 .

PMID:
18620515
2.

Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.

Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A.

Coron Artery Dis. 2003 May;14(3):213-8.

PMID:
12702924
3.

Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients.

Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelić-Ivanovic Z, Zunic G.

Clin Biochem. 2007 Feb;40(3-4):181-7. Epub 2006 Sep 30.

PMID:
17070511
4.

Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.

Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY.

J Am Acad Dermatol. 2009 Feb;60(2):225-30. doi: 10.1016/j.jaad.2008.09.046. Epub 2008 Nov 25.

PMID:
19028408
5.

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.

Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, Capetanaki Y, Boudoulas H, Kremastinos DT.

Eur J Clin Invest. 2010 Apr;40(4):288-93. doi: 10.1111/j.1365-2362.2010.02257.x.

PMID:
20192976
6.

Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.

Abdel-Azeez HA, Al-Zaky M.

J Clin Lab Anal. 2010;24(3):201-6. doi: 10.1002/jcla.20378.

PMID:
20486203
7.

Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease.

Ueno T, Watanabe H, Fukuda N, Tsunemi A, Tahira K, Matsumoto T, Takayama T, Chiku M, Saito S, Sato Y, Hirayama A, Matsumoto K, Soma M.

Med Sci Monit. 2009 Jul;15(7):CR341-8.

PMID:
19564823
8.

Oxidative stress and its association with coronary artery disease and different atherogenic risk factors.

Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC.

J Intern Med. 2004 Oct;256(4):308-15.

9.

Oxidative stress and homocysteine in coronary artery disease.

Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R, Guazzi MD.

Clin Chem. 2001 May;47(5):887-92.

10.

Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.

Snitcovsky I, Leitão GM, Pasini FS, Brunialti KC, Mangone FR, Maistro S, de Castro G Jr, Villar RC, Federico MH.

Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):807-11. doi: 10.1001/archoto.2009.103.

PMID:
19687403
11.

Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities.

Fabbi P, Ghigliotti G, Brunelli C, Balbi M, Spallarossa P, Rossettin P, Barsotti A, Odetti P, Garibaldi S.

J Lab Clin Med. 2004 Feb;143(2):99-105.

PMID:
14966465
12.

High plasma osteopontin levels in patients with inflammatory bowel disease.

Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, Omagari K, Mizuta Y, Ozono Y, Kohno S.

J Clin Gastroenterol. 2007 Feb;41(2):167-72.

PMID:
17245215
13.

Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.

Berezin AE, Kremzer AA.

Atherosclerosis. 2013 Aug;229(2):475-81. doi: 10.1016/j.atherosclerosis.2013.06.003. Epub 2013 Jun 25.

PMID:
23880208
14.

[Obesity and its' influence on reactive oxygen species (ROS) in the blood of patients with varicose veins of the lower limbs].

Kózka M, Krzyściak W, Pietrzycka A, Stepniewski M.

Przegl Lek. 2009;66(5):213-7. Polish.

PMID:
19739576
15.

An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease.

Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R.

Clin Biochem. 2008 Oct;41(14-15):1162-7. doi: 10.1016/j.clinbiochem.2008.07.005. Epub 2008 Jul 26.

PMID:
18692492
16.

Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.

Tousoulis D, Siasos G, Maniatis K, Oikonomou E, Kioufis S, Zaromitidou M, Paraskevopoulos T, Michalea S, Kollia C, Miliou A, Kokkou E, Papavassiliou AG, Stefanadis C.

Int J Cardiol. 2013 Sep 1;167(5):1924-8. doi: 10.1016/j.ijcard.2012.05.001. Epub 2012 May 27.

PMID:
22640692
17.

Plasma osteopontin is an independent prognostic marker for head and neck cancers.

Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT.

J Clin Oncol. 2006 Nov 20;24(33):5291-7.

PMID:
17114663
18.

The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.

Wang J, Hu B, Meng Y, Zhang C, Li K, Hui C.

Clin Biochem. 2009 Sep;42(13-14):1352-7. doi: 10.1016/j.clinbiochem.2009.05.016. Epub 2009 Jun 6.

PMID:
19501077
19.

Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.

Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D.

Eur Heart J. 2006 Apr;27(7):802-7. Epub 2006 Jan 18.

PMID:
16421174
20.

Studies on oxidative stress, serum iron and iron binding capacity in subjects prone to the risk of coronary artery disease.

Sharma SB, Dwivedi S, Kumar N, Prabhu KM, Madan N.

Indian Heart J. 2000 Sep-Oct;52(5):583-6.

PMID:
11256783

Supplemental Content

Support Center